Compounds > dactinomycin

dactinomycin and Minimal Disease, Residual

dactinomycin has been researched along with Minimal Disease, Residual in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Barbour, A; Beasley, GM; Carr, M; Coventry, BJ; Daou, H; Delman, KA; Farley, CR; Farma, JM; Farrow, NE; Henderson, MA; Kenyon-Smith, T; Kroon, HM; Lowe, MC; Miura, JT; Mosca, PJ; Mullen, D; Potdar, A; Serpell, J; Smithers, BM; Speakman, D; Sun, J; Teras, J; Thompson, JF; Tyler, DS; Zager, JS1
Beasley, GM; Chen, YA; Fisher, KJ; Tyler, DS; Wong, J; Zager, JS1
Coleman, RE; Gillett, S; Hancock, BW; Hills, A; Ireson, J; Singh, K; Tidy, JA; Winter, MC1
Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H1
Biron, P; Bompas, E; Droz, JP; Fléchon, A1
Culine, S; Droz, JP; Duvillard, P; Kattan, J; Lhomme, C; Michel, G1
Duckett, CP; Duckett, JW; Goldwein, J; Zderic, S1
Eickenberg, HU; Herwig, R; Roos, S; Schmid, H; Sievert, K; Weber, EA1
Matsuzaki, J; Miura, T; Miyoshi, Y1

Other Studies

9 other study(ies) available for dactinomycin and Minimal Disease, Residual

ArticleYear
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Annals of surgical oncology, 2020, Volume: 27, Issue:5

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Length of Stay; Lower Extremity; Male; Melanoma; Melphalan; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Progression-Free Survival; Skin Neoplasms; Treatment Outcome; Tumor Burden; United States; Upper Extremity

2020
Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prognosis; Remission Induction; Retrospective Studies; Survival Rate

2014
Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
    Gynecologic oncology, 2016, Volume: 143, Issue:3

    Topics: Adult; Antineoplastic Agents; Carboplatin; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm, Residual; Pregnancy; Retrospective Studies; Risk Assessment; Risk Factors; Uterine Neoplasms; Young Adult

2016
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine

2012
[Management of advanced seminoma: retrospective study of 96 patients].
    Bulletin du cancer, 2002, Volume: 89, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine

2002
Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Female; Germinoma; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm, Residual; Ovarian Neoplasms; Salvage Therapy; Vinblastine; Vincristine

1994
Brachytherapy for residual intra-renal Wilms' tumor.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Neoplasm, Residual; Vincristine; Wilms Tumor

1997
Pure primary choriocarcinoma of the urinary bladder with long-term survival.
    Urology, 2000, Nov-01, Volume: 56, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Reoperation; Urinary Bladder Neoplasms; Vincristine

2000
[Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
    Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm, Residual; Prognosis; Survival Rate; Testicular Neoplasms; Vinblastine

2000